View in EDS

Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.

Saved in:
Bibliographic Details
Title: Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.
Authors: Kuske M; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany., Westphal D; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Centre for Regenerative Therapies Dresden, TU Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany., Wehner R; Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany., Schmitz M; Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany., Beissert S; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany., Praetorius C; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Centre for Regenerative Therapies Dresden, TU Dresden, Germany., Meier F; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany. Electronic address: Friedegund.Meier@uniklinikum-dresden.de.
Source: Pharmacological research [Pharmacol Res] 2018 Oct; Vol. 136, pp. 151-159. Date of Electronic Publication: 2018 Aug 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30145328
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kuske+M%22">Kuske M</searchLink>; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Westphal+D%22">Westphal D</searchLink>; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Centre for Regenerative Therapies Dresden, TU Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wehner+R%22">Wehner R</searchLink>; Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitz+M%22">Schmitz M</searchLink>; Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Beissert+S%22">Beissert S</searchLink>; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Praetorius+C%22">Praetorius C</searchLink>; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Centre for Regenerative Therapies Dresden, TU Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Meier+F%22">Meier F</searchLink>; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; National Centre for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany; Skin Cancer Centre at the University Cancer Center Dresden, Germany. Electronic address: Friedegund.Meier@uniklinikum-dresden.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228907422%22">Pharmacological research</searchLink> [Pharmacol Res] 2018 Oct; Vol. 136, pp. 151-159. <i>Date of Electronic Publication: </i>2018 Aug 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8907422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-1186 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210436618%22">10436618 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30145328
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.phrs.2018.08.019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 151
    Titles:
      – TitleFull: Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kuske M
      – PersonEntity:
          Name:
            NameFull: Westphal D
      – PersonEntity:
          Name:
            NameFull: Wehner R
      – PersonEntity:
          Name:
            NameFull: Schmitz M
      – PersonEntity:
          Name:
            NameFull: Beissert S
      – PersonEntity:
          Name:
            NameFull: Praetorius C
      – PersonEntity:
          Name:
            NameFull: Meier F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2018 Oct
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1096-1186
          Numbering:
            – Type: volume
              Value: 136
          Titles:
            – TitleFull: Pharmacological research
              Type: main
ResultId 1